Lung cancer remains the commonest cause of cancer death in both men and women in the
developed world, although mortality rates for men are dropping. Spiral computed …

Objectives Stage III non-small cell lung cancer (NSCLC) describes a heterogeneous
population with disease presentation ranging from apparently resectable tumors with occult …

Patients with stage IIIA non–small cell lung cancer, determined based on involvement of
ipsilateral mediastinal lymph nodes, represent the most challenging management problem …

In 1989, we began a multicenter study to evaluate the potential benefit of preoperative
chemotherapy with cisplatin, ifosfamide and mitomycin over surgery alone in CT-visible N2 …

The aim was to investigate the efficacy of neoadjuvant docetaxel–cisplatin and identify
prognostic factors for outcome in locally advanced stage IIIA (pN2 by mediastinoscopy) non …

Objective: We performed a prospective randomized trial in patients with potentially
resectable stage IIIA N2 non-small cell lung cancer to confirm the efficacy of induction …

Introduction: Our study aimed to evaluate whether pathologic complete response (pCR) in
early-stage non–small-cell lung cancer (NSCLC) after neoadjuvant chemotherapy resulted …

Introduction Optimal management of clinical stage IIIA-N2 non–small-cell lung cancer
(NSCLC) is controversial. This study examines whether neoadjuvant chemoradiation plus …

Background. The 2-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET)
imaging is an advance over computed tomography alone in the staging of untreated …

Objectives: The treatment of nonseminomatous germ cell tumors with cisplatin-based
chemotherapy followed by aggressive surgical resection of residual disease is one of the …